“Worst drug approval decision in recent US history”

June 30, 2021
Research and Development

The FDA’s decision to accelerate approval for Aduhelm, the first new drug for Alzheimer’s in two decades, has been met …

img_4190-e1376666350337-web

Sickle cell therapy granted innovation passport by MHRA

June 30, 2021
Research and Development MHRA, SCD, brexit

Bluebird bio has been granted an innovation passport, under the new UK approval process, for LentiGlobin (bb1111) a promising treatment …

bms_european_hq_in_rueil_1

EU approves BMS’s treatment for metastatic colorectal cancer

June 30, 2021
Research and Development

The EU has approved Opdivo (nivolumab) plus Yervoy (ipilimumab) for the treatment of metastatic colorectal cancer. The treatment will be …

xxx

RNA breakthrough: Fluorescence used to track molecule movement

June 30, 2021
Research and Development AstraZeneca, RNA, mrna

Researchers at Chalmers University of Technology in Sweden have announced a breakthrough in the labelling method of messenger RNA (mRNA) …

EU approves Merck’s treatment for oesophageal cancer

June 30, 2021
Research and Development

The EU has approved Merck’s KEYTRUDA, in combination with platinum- and fluoropyrimidine-based chemotherapy, as treatment for advanced oesophageal cancer. The …

cnb210_muli-organ-image_v1

Next generation organ-on-a-chip technology adopted by King’s College London

June 29, 2021
Manufacturing and Production organ-on-a-chip, research collaboration, technology, university

CN Bio, an organ-on-a-chip company that designs and manufactures single and multi-organ microphysiological systems (MPS), has announced that their novel …

stock-incyte-01-shutter

CHMP issue positive opinion for Incyte and MorphoSys’ tafasitamab

June 29, 2021
Manufacturing and Production CHMP, EMA, EU, FDA, US

Incyte and MorphoSys have announced that the EMA’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive …

andrei_r_-_shutterstock_1935537274_720

Quantoom & eTheRNA to collaborate on revolutionary RNA production system

June 29, 2021
Manufacturing and Production RNA, collaboration

Quantoom and eTheRNA immunotherapies have announced a strategic collaboration to develop a revolutionary RNA production system (RPS) for both research …

NICE recommends that all women should do pelvic floor exercises

June 29, 2021
Manufacturing and Production NHS, NICE, pelvic floor, women's health

NICE has recommended in draft guidance that girls as young as 12 should be encouraged to do pelvic floor muscle …

mufid-majnun-oi20ehignd4-unsplash

Avacta’s lateral flow test can detect Delta variant

June 29, 2021
Manufacturing and Production Avacta, COVID-19, Delta variant, antigen lateral flow test

A study has shown that Avacta’s AffiDX antigen lateral flow test can detect the Delta variant of COVID-19. The test …

credit_-_daniel_leal-olivas-afp

Astellas receives positive CHMP opinion for symptomatic anaemia drug

June 28, 2021
Sales and Marketing Astellas, CKD, anaemia

Astellas and FibroGen have announced that the Committee for Medicinal Products for Human Use (CHMP) of the EMA has adopted …

biogen_austria_238

Samsung Bioepis & Biogen receive positive CHMP opinion for ranibizumab biosimilar

June 28, 2021
Sales and Marketing EC, EMA, EU, biosimilars

Samsung Bioepis and Biogen have announced that the EMA’s Committee for Medicinal Products for Human Use (CHMP) has adopted a …

lilly_entrance_web

Eli Lilly’s Type 2 diabetes drug outperforms semaglutide in trials

June 28, 2021
Sales and Marketing Eli Lilly, semaglutide, type 2 diabetes

Eli Lilly has announced that the SURPASS-2 clinical trial has shown tirzepatide achieved superior HbA1C and body weight reductions compared …

laboratory-testing-az

Polyphor’s future in question after co-primary endpoint in breast cancer study missed

June 28, 2021
Sales and Marketing Primary Endpoint, breast cancer

Swiss biopharmaceutical company, Polyphor, has announced that its global Phase III study, FORTRESS, evaluating balixafortide (POL6326) in combination with eribulin …

Medical cannabis formulation kills breast cancer cells in trial

June 28, 2021
Sales and Marketing breast cancer, medical cannabis, oncology

UK-based pharma company, Apollon Formularies, have announced that their medical cannabis formulations were successful in killing triple-negative breast cancer (TNBC) …

Tapeworm drug to be trialled nationally as COVID treatment

June 25, 2021
Medical Communications COVID-19, NHS, dialysis, kindey, tapeworm

Kidney patients in Bristol are being offered a clinical trial to see whether a drug used for tapeworm patients can …

Eli Lilly to seek FDA approval for experimental Alzheimer’s drug

June 25, 2021
Medical Communications Alzheimer's, Eli Lilly, FDA

Eli Lilly plans to seek accelerated FDA approval for its experimental Alzheimer’s drug donanemab, announcing plans on Thursday to file …

laboratory-testing-az

Exscientia to collaborate with EQRx on drug development

June 25, 2021
Medical Communications AI, Exscientia, clinical drug development

Exscientia and EQRx have announced a strategic research and development collaboration agreement aiming to substantially accelerate the delivery of novel …

New test proven to detect over 50 types of cancer

June 25, 2021
Medical Communications Cancer. test, US, oncology

Final results from a study into a new blood test that can detect more than 50 types of cancer have …

sanofi_hq__boetie_hall_small_

Sanofi’s NSCLC drug gains EC approval

June 25, 2021
Medical Communications EC, EU, NSCLC, Sanofi

The European Commission (EC) has approved Sanofi and Regeneron’s PD-1 inhibitor, Libtayo (cemiplimab), for the first-line treatment of adults with …

The Gateway to Local Adoption Series

Latest content